Pulmonary fibrosis is a severe and life shortening chronic condition. Although most people experience mild symptoms of COVID-19, some patients develop serious and life-threatening conditions with severe lung damage. In order to influence the outcome of the disease, the project aims to establish methods to identify risk groups at an early stage.
|Effective start/end date||2020/05/07 → …|
- Lund University (lead)
- Karolinska Institutet
UKÄ subject classification
- Respiratory Medicine and Allergy